Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Waning of vaccine effectiveness against Omicron infection occurs within a matter of months.
“allowing more time for waning of VE against Omicron infection, which occurs within a matter of months [7].”
From Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization (2023) · cites this paper as [7]
Vaccine protection against severe disease has been shown to wane much less rapidly than against symptomatic infection.
“vaccine protection against severe disease has been shown to wane much less rapidly than against symptomatic infection [7,34].”
From Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization (2023) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 2 · Cited by 136
- Authors
- Higdon, M. M., Baidya, A., Walter, K. K., Patel, M. K., Issa, H., Espié, E., Feikin, D. R., & Knoll, M. D.
- Affiliations
- Johns Hopkins University (US)
- World Health Organization (CH)
- Coalition for Epidemic Preparedness Innovations (NO)
- Corresponding author
- Higdon, Melissa M
- ORCID
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 22
- Issue
- 8
- Pages
- 1114-1116
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC9221361
- OpenAlex
- W4283326436
- Cited by
- 136
- References
- 2
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 60 · 2022: 25
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Coalition for Epidemic Preparedness Innovations
- Merck
- World Health Organization
- Bill and Melinda Gates Foundation
- Asian Development Bank
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 vaccination, Omicron variant, SARS-CoV-2, vaccine effectiveness, duration of protection, booster vaccination, clinical outcomes
- MeSH terms
- COVID-19, SARS-CoV-2, Humans, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
